BEGIN:VCALENDAR VERSION:2.0 PRODID:-//events.la.psu.edu//EN CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:STANDARD DTSTART:20201101T020000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU END:STANDARD BEGIN:DAYLIGHT DTSTART:20200308T020000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT UID:6125-9291297ec4a463be39324dc3d95104a4@events.la.psu.edu DTSTAMP:20260508T143407Z DTSTART;TZID=America/New_York:20191016T161500 DTEND;TZID=America/New_York:20191016T161500 SUMMARY:Child Study Center Speaker Series DESCRIPTION:\nKatie Witkiewitz\, Ph.D.\n\nRegent'\;s Professor\n\nAre a Head: Quantitative/Methodology\, Department of Psychology\n\nThe Unive rsity of New Mexico\n\nAlcohol Harm Reduction is Health Promotion: A 15- year Journey Examining Patterns and Predictors of Alcohol Treatment Outc omes\n\nAbstract: Abstinence from alcohol is often viewed as the most de sirable and ideal outcome for individuals with alcohol use disorder. Yet \, most individuals with alcohol use disorder do not want to abstain fro m drinking and do not seek treatment. Several studies of treatment seeki ng and population-based non-treatment seeking samples have found that si gnificant reductions in alcohol use during and following treatment\, or over time in the absence of treatment\, are common among individuals wit h alcohol use disorder. Reductions in drinking are associated with signi ficant improvements in health\, quality of life\, and other consequences of alcohol use disorder\, and also stable over time. Over the past 15 y ears\, there have been several significant methodological advances in st udying patterns and predictors of alcohol use and drinking reductions\, yet most of the work has not had a major influence on clinical practice\ , and has had no effect on regulatory guidance for clinical trials exami ning new medications for alcohol use disorder in the United States. The current talk will provide a broad overview of this literature and presen t new data on the validity of World Health Organization drinking risk le vels as a harm reduction endpoint. Results from several recent studies p rovide evidence that reductions in World Health Organization drinking ri sk levels are a viable alternative to abstinence as a harm reduction str ategy and as an endpoint for alcohol clinical trials. The talk will also highlight the importance of drinking reductions as a significant public health priority.\n\nCo-sponsored with the Edna Bennett Pierce Preventio n Research Center\n\nFor more details: https://events.la.psu.edu/event/c hild_study_center_speaker_series_5477/ X-ALT-DESC;FMTTYPE=text/html:

Katie Witkie witz, Ph.D.
Regent's Professor
Area Head: Quantitative /Methodology, Department of Psychology
The University of New Mexico

Alcohol Harm Reduction is Health Promotion: A 15-year Journ ey Examining Patterns and Predictors of Alcohol Treatment Outcomes

Abstract: Abstinence from alcohol is often viewed as the most d esirable and ideal outcome for individuals with alcohol use disorder. Ye t, most individuals with alcohol use disorder do not want to abstain fro m drinking and do not seek treatment. Several studies of treatment seeki ng and population-based non-treatment seeking samples have found that si gnificant reductions in alcohol use during and following treatment, or o ver time in the absence of treatment, are common among individuals with alcohol use disorder. Reductions in drinking are associated with signifi cant improvements in health, quality of life, and other consequences of alcohol use disorder, and also stable over time. Over the past 15 years, there have been several significant methodological advances in studying patterns and predictors of alcohol use and drinking reductions, yet mos t of the work has not had a major influence on clinical practice, and ha s had no effect on regulatory guidance for clinical trials examining new medications for alcohol use disorder in the United States. The current talk will provide a broad overview of this literature and present new da ta on the validity of World Health Organization drinking risk levels as a harm reduction endpoint. Results from several recent studies provide e vidence that reductions in World Health Organization drinking risk level s are a viable alternative to abstinence as a harm reduction strategy an d as an endpoint for alcohol clinical trials. The talk will also highlig ht the importance of drinking reductions as a significant public health priority.

Co-sponsored with the Edna Bennett Pierce Prevention Res earch Center

For more de tails: https://events.la.psu.edu/event/child_study_center_spea ker_series_5477/

URL:https://csc.la.psu.edu/speaker-series/2019-2020-speaker-series LOCATION:Memorial Lounge, 107 Pasquerilla Spiritual Center END:VEVENT END:VCALENDAR